PEB resources
The simulators
Before you open any of these tools
None of these simulators is medical advice, and none replaces a clinical examination. They apply group averages and regulatory schedules to a situation described in a handful of fields. They know nothing of the case. Any treatment decision is made with a doctor, never in front of a screen.
Available in English
Equivalences and tapering
Switching, adjusting or tapering a benzodiazepine
Equivalence tables are validated by no clinical measurement, and no trial compares two tapering speeds. The simulator shows what each source claims, and flags what none of them settles.
Applied critical appraisal
Better sleep: the rules that hold up
Twenty-five sleep hygiene rules, each weighted by what its literature actually shows rather than by how often it is repeated. The red flags come before the score. The tool separates what is demonstrated from what has been copied for thirty years, and says which of your answers warrant a consultation.
Drug interactions and cardiac risk
Psychotropic combinations and cardiac risk
Two or more psychotropics, somatic co-prescriptions, risk factors and the QT on the ECG. For each pair, the simulator gives the level set by the French ANSM guide, the SmPC and the FDA label, then what the literature demonstrates, suggests or leaves open.
Not translated yet
Regulatory monitoring
Where are you in clozapine monitoring?
Two dates are enough. The tool rebuilds the neutrophil monitoring schedule, places the patient within it, computes the date of the next count and gives the course of action for a given neutrophil figure, benign ethnic neutropenia thresholds included.
Regulatory monitoring
Where are you in cardiometabolic monitoring?
Nine monitoring parameters under antipsychotic treatment, sorted into what is up to date, what is overdue and what is coming. The tool produces a schedule item by item and a document to file in the record. Two readings, professional or patient.
Applied critical appraisal
Weight and psychotropic drugs
What a treatment does to the body and what stopping it does to relapse risk, shown side by side for schizophrenia, depression and bipolar disorder. The second part lets you switch on the four graphical devices that rig the comparison without changing a single figure.
Why some tools are still in French. Psychiatry Evidence Base publishes in French, and the English edition is built one piece at a time. The greyed cards open the French page, which works in any browser translator. They turn to full colour as each translation is published.